Business● LowSep 28 · Sep 28, 2026, 3:24 PM
Kodiak Sciences skyrockets as Zenkuda, tabirafusp excel in late-stage wet AMD trial
GlobeAlert Desk · curated from Seeking Alpha Tech · North America
Kodiak Sciences' stock has surged following excellent results from Zenkuda and tabirafusp in their late-stage wet AMD trial. This positive outcome indicates a significant development for the company and its experimental treatments.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
North America theater · last 7 days
rising · 28 in the last 24h1,120
events logged
95
risk index / 100
Wildfires 600Attacks & Assaults 188Robberies & Theft 148Shootings 89Rocket Launches 38
- Cyber activity (148 reports)Cyber Threats · United States · 7m ago
- Protest activity (107 reports)Protests · United States · 7m ago
- Conflict activity (133 reports)Conflict Events · United States · 7m ago
More in Business
Business35m agoFuel prices drop this weekRTP Notícias · PortugalBusiness36m agoIryo will maintain minimum services of 70% during tomorrow's railway strikeInfobae · ArgentinaBusiness37m ago‘Unreasonable demands’: Waugh lashes players union as pay dispute heads to the courtsSydney Morning Herald · AustraliaBusiness37m agoThe Ibex 35 opens with a 0.2% rise and approaches 20,100 pointsInfobae · Argentina